Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00580463|
Recruitment Status : Completed
First Posted : December 24, 2007
Last Update Posted : March 19, 2009
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease|
|Primary or Metastatic Central Nervous System (CNS) Tumor|
|Study Type :||Observational|
|Actual Enrollment :||1128 participants|
|Official Title:||Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors|
|Study Start Date :||January 2000|
|Actual Primary Completion Date :||March 2009|
|Actual Study Completion Date :||March 2009|
- To establish a repository of CNS tumors or metastases to the CNS and related tissues for current or future studies. [ Time Frame: conclusion of the study ]
Biospecimen Retention: Samples With DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||Child, Adult, Older Adult|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- For acquisition of intra-operative brain or spine tumor specimens, blood specimens and spinal fluid specimens, all patients who undergo surgery for resection or biopsy qualify for inclusion in this protocol.
- If spinal fluid is not accessed as part of the operative procedure, it will not be collected.
- All patients must be under the care of one or more members of the MSKCC CNS disease management team at the time of tissue acquisition. Patients may have been previously diagnosed and/or treated at another institution.
- Subjects are eligible regardless of sex, age or race.
- Parental or guardian consents will be obtained in the case of minors (less than 18 years of age)
- Patients or their guardians, in case of a minor, may choose to be excluded at any time.
- If a patient, or guardian, decides to withdraw after some or all of the tissues have been collected, such tissues will be destroyed at their request.
- Patients or their guardians will be counseled at the time of obtaining their consent, of the possibility of withdrawing from the protocol.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00580463
|United States, New York|
|Memorial Sloan-Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Philip Gutin, MD||Memorial Sloan Kettering Cancer Center|
|Responsible Party:||Philip Gutin, MD, Memorial Sloan-Kettering Cancer Center|
|Other Study ID Numbers:||
|First Posted:||December 24, 2007 Key Record Dates|
|Last Update Posted:||March 19, 2009|
|Last Verified:||March 2009|
central nervous system (CNS) tumor